CRISPR, tomatoes

Intellia Therapeutics CEO John Leonard has, for the last couple years, found himself stuck in a financial Groundhog Day.
It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.
CRISPR Therapeutics ( CRSP -5.91%) made a name for itself by pioneering advanced gene therapies made with technologies that didn't exist a generation ago. Now, its challenge is to build on its prior ...
Life Sciences Center (LSC) have discovered a unique way for cells to silence specific genes without cutting DNA. This ...
EST Cathie Wood’s ARK Investment bought 178.1K shares of Crispr Therapeutics (CRSP) today Published first on TheFly – the ...
In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for ...
Genes contain instructions for making proteins, and a central dogma of biology is that this information flows from DNA to RNA ...